Estimating overdiagnosis in lung cancer screening: Reply

JAMA Internal Medicine

Volumn 174, Issue 7, 2014, Pages 1198-1199

  Patz Jr , Edward F ^a   Pinsky, Paul ^b   Kramer, Barnett S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; HEALTH CARE COST; HUMAN; LETTER; LUNG CANCER; LUNG NON SMALL CELL CANCER; MORBIDITY; PATIENT MONITORING; PRIORITY JOURNAL; DIAGNOSTIC ERROR; FEMALE; LUNG TUMOR; MALE; MASS SCREENING; METHODOLOGY; NOTE; RADIOGRAPHY;

CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904123660     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.1525     Document Type: Letter

References (2)

1. Patz EF Jr, Pinsky P, Gatsonis C, et al; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174(2):269-274.
2. Zahl PH, Jørgensen KJ, Gøtzsche PC. Lead-time models should not be used to estimate overdiagnosis in cancer screening [published online March 4, 2014]. J Gen Intern Med. doi:10.1007/s11606-014-2812-2.